Compass Group FY22 Profit Surges, Lifts Dividend; Sees Underlying Growth In FY23

Compass Group Plc (CPG.L,CMPGF.PK), a British food services provider, reported Monday that its fiscal 2022 profit before tax surged to 1.47 billion pounds from last year's 464 million pounds.

Basic earnings per share were 62.6 pence, an increase of 213 percent from last year's 20 pence.

Underlying profit before tax was 1.49 billion pounds, compared to 698 million pounds a year ago. Basic underlying earnings per share were 63.0 pence, compared to 30.9 pence last year.

Revenue increased 42.5 percent to 25.5 billion pounds from 17.9 billion pounds a year ago. Organic revenue growth was 37.5 percent.

Further, Compass Group announced that annual dividend per share increased 125 percent to 31.5 pence from 14 pence a year ago.

The company also announced a further share buyback of up to 250 million pounds, to take place during the first half of the 2023 financial year, taking the total buyback to 750 million pounds.

Looking ahead for 2023, Compass Group expects underlying operating profit growth to be above 20 percent on a constant-currency basis, with organic revenue growth of around 15 percent, weighted towards the first half of the year.

Underlying operating margin is expected above 6.5 percent.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT